 | • レポートコード：MRC2-11QY12640 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は黒色腫のグローバル市場について調査・分析したレポートです。種類別（表在性黒色腫、結節型黒色腫、悪性黒子型黒色腫（LMM）、末端黒子型黒色腫）市場規模、用途別（病院、製薬会社、研究センター、クリニック、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別黒色腫の競争状況、市場シェア ・世界の黒色腫市場：種類別市場規模 2015年-2020年（表在性黒色腫、結節型黒色腫、悪性黒子型黒色腫（LMM）、末端黒子型黒色腫） ・世界の黒色腫市場：種類別市場規模予測 2021年-2026年（表在性黒色腫、結節型黒色腫、悪性黒子型黒色腫（LMM）、末端黒子型黒色腫） ・世界の黒色腫市場：用途別市場規模 2015年-2020年（病院、製薬会社、研究センター、クリニック、研究所） ・世界の黒色腫市場：用途別市場規模予測 2021年-2026年（病院、製薬会社、研究センター、クリニック、研究所） ・北米の黒色腫市場分析：米国、カナダ ・ヨーロッパの黒色腫市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの黒色腫市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の黒色腫市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの黒色腫市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Amgen、Eristol-Mayers Squibb、Eisai、Roche、Genetech、Janssen Biotech、Pfizer、Novartis、Vical、Ziopharm ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are most common on the back. Sometimes they develop from a mole with changes such as an increase in size, irregular edges, change in color, itchiness, or skin breakdown.
Confirmation of the clinical diagnosis is done with a skin biopsy. It is usually followed up with a wider excision of the scar or tumor. Depending on the stage, a sentinel lymph node biopsy may be performed. Treatment of advanced malignant melanoma is performed from a multidisciplinary approach.
Market Analysis and Insights: Global Melanoma Market
The global Melanoma market size is projected to reach US$ 5938.9 million by 2026, from US$ 5536.4 million in 2020, at a CAGR of 6.7%% during 2021-2026.
Global Melanoma Scope and Market Size
Melanoma market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Melanoma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Amgen
Eristol-Mayers Squibb
Eisai
Roche
Genetech
Janssen Biotech
Pfizer
Novartis
Vical
Ziopharm
Market segment by Type, the product can be split into
Superficial Melanoma
Nodular Melanoma
Lentigo Maglina Melanoma
Acral Lentigious
Market segment by Application, split into
Hospitals
Pharmaceutical Companies
Research Centres
Clinics
Laboratories
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Melanoma Revenue
1.4 Market by Type
1.4.1 Global Melanoma Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Superficial Melanoma
1.4.3 Nodular Melanoma
1.4.4 Lentigo Maglina Melanoma
1.4.5 Acral Lentigious
1.5 Market by Application
1.5.1 Global Melanoma Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Pharmaceutical Companies
1.5.4 Research Centres
1.5.5 Clinics
1.5.6 Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Melanoma Market Perspective (2015-2026)
2.2 Global Melanoma Growth Trends by Regions
2.2.1 Melanoma Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Melanoma Historic Market Share by Regions (2015-2020)
2.2.3 Melanoma Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Melanoma Market Growth Strategy
2.3.6 Primary Interviews with Key Melanoma Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Melanoma Players by Market Size
3.1.1 Global Top Melanoma Players by Revenue (2015-2020)
3.1.2 Global Melanoma Revenue Market Share by Players (2015-2020)
3.1.3 Global Melanoma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Melanoma Market Concentration Ratio
3.2.1 Global Melanoma Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Melanoma Revenue in 2019
3.3 Melanoma Key Players Head office and Area Served
3.4 Key Players Melanoma Product Solution and Service
3.5 Date of Enter into Melanoma Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Melanoma Historic Market Size by Type (2015-2020)
4.2 Global Melanoma Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Melanoma Market Size by Application (2015-2020)
5.2 Global Melanoma Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Melanoma Market Size (2015-2020)
6.2 Melanoma Key Players in North America (2019-2020)
6.3 North America Melanoma Market Size by Type (2015-2020)
6.4 North America Melanoma Market Size by Application (2015-2020)
7 Europe
7.1 Europe Melanoma Market Size (2015-2020)
7.2 Melanoma Key Players in Europe (2019-2020)
7.3 Europe Melanoma Market Size by Type (2015-2020)
7.4 Europe Melanoma Market Size by Application (2015-2020)
8 China
8.1 China Melanoma Market Size (2015-2020)
8.2 Melanoma Key Players in China (2019-2020)
8.3 China Melanoma Market Size by Type (2015-2020)
8.4 China Melanoma Market Size by Application (2015-2020)
9 Japan
9.1 Japan Melanoma Market Size (2015-2020)
9.2 Melanoma Key Players in Japan (2019-2020)
9.3 Japan Melanoma Market Size by Type (2015-2020)
9.4 Japan Melanoma Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Melanoma Market Size (2015-2020)
10.2 Melanoma Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Melanoma Market Size by Type (2015-2020)
10.4 Southeast Asia Melanoma Market Size by Application (2015-2020)
11 India
11.1 India Melanoma Market Size (2015-2020)
11.2 Melanoma Key Players in India (2019-2020)
11.3 India Melanoma Market Size by Type (2015-2020)
11.4 India Melanoma Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Melanoma Market Size (2015-2020)
12.2 Melanoma Key Players in Central & South America (2019-2020)
12.3 Central & South America Melanoma Market Size by Type (2015-2020)
12.4 Central & South America Melanoma Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Amgen
13.1.1 Amgen Company Details
13.1.2 Amgen Business Overview
13.1.3 Amgen Melanoma Introduction
13.1.4 Amgen Revenue in Melanoma Business (2015-2020))
13.1.5 Amgen Recent Development
13.2 Eristol-Mayers Squibb
13.2.1 Eristol-Mayers Squibb Company Details
13.2.2 Eristol-Mayers Squibb Business Overview
13.2.3 Eristol-Mayers Squibb Melanoma Introduction
13.2.4 Eristol-Mayers Squibb Revenue in Melanoma Business (2015-2020)
13.2.5 Eristol-Mayers Squibb Recent Development
13.3 Eisai
13.3.1 Eisai Company Details
13.3.2 Eisai Business Overview
13.3.3 Eisai Melanoma Introduction
13.3.4 Eisai Revenue in Melanoma Business (2015-2020)
13.3.5 Eisai Recent Development
13.4 Roche
13.4.1 Roche Company Details
13.4.2 Roche Business Overview
13.4.3 Roche Melanoma Introduction
13.4.4 Roche Revenue in Melanoma Business (2015-2020)
13.4.5 Roche Recent Development
13.5 Genetech
13.5.1 Genetech Company Details
13.5.2 Genetech Business Overview
13.5.3 Genetech Melanoma Introduction
13.5.4 Genetech Revenue in Melanoma Business (2015-2020)
13.5.5 Genetech Recent Development
13.6 Janssen Biotech
13.6.1 Janssen Biotech Company Details
13.6.2 Janssen Biotech Business Overview
13.6.3 Janssen Biotech Melanoma Introduction
13.6.4 Janssen Biotech Revenue in Melanoma Business (2015-2020)
13.6.5 Janssen Biotech Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Melanoma Introduction
13.7.4 Pfizer Revenue in Melanoma Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Novartis
13.8.1 Novartis Company Details
13.8.2 Novartis Business Overview
13.8.3 Novartis Melanoma Introduction
13.8.4 Novartis Revenue in Melanoma Business (2015-2020)
13.8.5 Novartis Recent Development
13.9 Vical
13.9.1 Vical Company Details
13.9.2 Vical Business Overview
13.9.3 Vical Melanoma Introduction
13.9.4 Vical Revenue in Melanoma Business (2015-2020)
13.9.5 Vical Recent Development
13.10 Ziopharm
13.10.1 Ziopharm Company Details
13.10.2 Ziopharm Business Overview
13.10.3 Ziopharm Melanoma Introduction
13.10.4 Ziopharm Revenue in Melanoma Business (2015-2020)
13.10.5 Ziopharm Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Melanoma Key Market Segments
Table 2. Key Players Covered: Ranking by Melanoma Revenue
Table 3. Ranking of Global Top Melanoma Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Melanoma Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Superficial Melanoma
Table 6. Key Players of Nodular Melanoma
Table 7. Key Players of Lentigo Maglina Melanoma
Table 8. Key Players of Acral Lentigious
Table 9. Global Melanoma Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Melanoma Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Melanoma Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Melanoma Market Share by Regions (2015-2020)
Table 13. Global Melanoma Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Melanoma Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Melanoma Market Growth Strategy
Table 19. Main Points Interviewed from Key Melanoma Players
Table 20. Global Melanoma Revenue by Players (2015-2020) (Million US$)
Table 21. Global Melanoma Market Share by Players (2015-2020)
Table 22. Global Top Melanoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanoma as of 2019)
Table 23. Global Melanoma by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Melanoma Product Solution and Service
Table 26. Date of Enter into Melanoma Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Melanoma Market Size by Type (2015-2020) (Million US$)
Table 29. Global Melanoma Market Size Share by Type (2015-2020)
Table 30. Global Melanoma Revenue Market Share by Type (2021-2026)
Table 31. Global Melanoma Market Size Share by Application (2015-2020)
Table 32. Global Melanoma Market Size by Application (2015-2020) (Million US$)
Table 33. Global Melanoma Market Size Share by Application (2021-2026)
Table 34. North America Key Players Melanoma Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Melanoma Market Share (2019-2020)
Table 36. North America Melanoma Market Size by Type (2015-2020) (Million US$)
Table 37. North America Melanoma Market Share by Type (2015-2020)
Table 38. North America Melanoma Market Size by Application (2015-2020) (Million US$)
Table 39. North America Melanoma Market Share by Application (2015-2020)
Table 40. Europe Key Players Melanoma Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Melanoma Market Share (2019-2020)
Table 42. Europe Melanoma Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Melanoma Market Share by Type (2015-2020)
Table 44. Europe Melanoma Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Melanoma Market Share by Application (2015-2020)
Table 46. China Key Players Melanoma Revenue (2019-2020) (Million US$)
Table 47. China Key Players Melanoma Market Share (2019-2020)
Table 48. China Melanoma Market Size by Type (2015-2020) (Million US$)
Table 49. China Melanoma Market Share by Type (2015-2020)
Table 50. China Melanoma Market Size by Application (2015-2020) (Million US$)
Table 51. China Melanoma Market Share by Application (2015-2020)
Table 52. Japan Key Players Melanoma Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Melanoma Market Share (2019-2020)
Table 54. Japan Melanoma Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Melanoma Market Share by Type (2015-2020)
Table 56. Japan Melanoma Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Melanoma Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Melanoma Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Melanoma Market Share (2019-2020)
Table 60. Southeast Asia Melanoma Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Melanoma Market Share by Type (2015-2020)
Table 62. Southeast Asia Melanoma Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Melanoma Market Share by Application (2015-2020)
Table 64. India Key Players Melanoma Revenue (2019-2020) (Million US$)
Table 65. India Key Players Melanoma Market Share (2019-2020)
Table 66. India Melanoma Market Size by Type (2015-2020) (Million US$)
Table 67. India Melanoma Market Share by Type (2015-2020)
Table 68. India Melanoma Market Size by Application (2015-2020) (Million US$)
Table 69. India Melanoma Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Melanoma Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Melanoma Market Share (2019-2020)
Table 72. Central & South America Melanoma Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Melanoma Market Share by Type (2015-2020)
Table 74. Central & South America Melanoma Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Melanoma Market Share by Application (2015-2020)
Table 76. Amgen Company Details
Table 77. Amgen Business Overview
Table 78. Amgen Product
Table 79. Amgen Revenue in Melanoma Business (2015-2020) (Million US$)
Table 80. Amgen Recent Development
Table 81. Eristol-Mayers Squibb Company Details
Table 82. Eristol-Mayers Squibb Business Overview
Table 83. Eristol-Mayers Squibb Product
Table 84. Eristol-Mayers Squibb Revenue in Melanoma Business (2015-2020) (Million US$)
Table 85. Eristol-Mayers Squibb Recent Development
Table 86. Eisai Company Details
Table 87. Eisai Business Overview
Table 88. Eisai Product
Table 89. Eisai Revenue in Melanoma Business (2015-2020) (Million US$)
Table 90. Eisai Recent Development
Table 91. Roche Company Details
Table 92. Roche Business Overview
Table 93. Roche Product
Table 94. Roche Revenue in Melanoma Business (2015-2020) (Million US$)
Table 95. Roche Recent Development
Table 96. Genetech Company Details
Table 97. Genetech Business Overview
Table 98. Genetech Product
Table 99. Genetech Revenue in Melanoma Business (2015-2020) (Million US$)
Table 100. Genetech Recent Development
Table 101. Janssen Biotech Company Details
Table 102. Janssen Biotech Business Overview
Table 103. Janssen Biotech Product
Table 104. Janssen Biotech Revenue in Melanoma Business (2015-2020) (Million US$)
Table 105. Janssen Biotech Recent Development
Table 106. Pfizer Company Details
Table 107. Pfizer Business Overview
Table 108. Pfizer Product
Table 109. Pfizer Revenue in Melanoma Business (2015-2020) (Million US$)
Table 110. Pfizer Recent Development
Table 111. Novartis Business Overview
Table 112. Novartis Product
Table 113. Novartis Company Details
Table 114. Novartis Revenue in Melanoma Business (2015-2020) (Million US$)
Table 115. Novartis Recent Development
Table 116. Vical Company Details
Table 117. Vical Business Overview
Table 118. Vical Product
Table 119. Vical Revenue in Melanoma Business (2015-2020) (Million US$)
Table 120. Vical Recent Development
Table 121. Ziopharm Company Details
Table 122. Ziopharm Business Overview
Table 123. Ziopharm Product
Table 124. Ziopharm Revenue in Melanoma Business (2015-2020) (Million US$)
Table 125. Ziopharm Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Melanoma Market Share by Type: 2020 VS 2026
Figure 2. Superficial Melanoma Features
Figure 3. Nodular Melanoma Features
Figure 4. Lentigo Maglina Melanoma Features
Figure 5. Acral Lentigious Features
Figure 6. Global Melanoma Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Research Centres Case Studies
Figure 10. Clinics Case Studies
Figure 11. Laboratories Case Studies
Figure 12. Melanoma Report Years Considered
Figure 13. Global Melanoma Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Melanoma Market Share by Regions: 2020 VS 2026
Figure 15. Global Melanoma Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Melanoma Market Share by Players in 2019
Figure 18. Global Top Melanoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanoma as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Melanoma Revenue in 2019
Figure 20. North America Melanoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Melanoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Melanoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Melanoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Melanoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Melanoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Melanoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
悪性黒子型黒色腫治療薬の世界市場（～2026年） Lentigo maligna is a subtype of melanoma in situ that is characterized by an atypical proliferation of melanocytes within the basal epidermis; lentigo maligna that invades the dermis is termed lentigo maligna melanoma. Market Analysis and Insights: Global Lentigo Maligna Melanoma Therapeutic Market …- 黒色腫がんの世界市場（～2026年） Melanoma Cancer is a skin cancer that develops due to expose of UV rays on the skin. Increasing incidence of melanoma across the globe and rising ozone layer depletion due to global warming are the major factors that are driving the market during the forecast period. Additionally, overexposure to ra…
- 非黒色腫皮膚がんの世界市場（～2026年） Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlike…
- 非黒色腫皮膚がん治療の世界市場（～2026年） Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlike…
- 転移性ブドウ膜黒色腫治療薬の世界市場（～2026年） Market Analysis and Insights: Global Metastatic Uveal Melanoma Thereapeutics Market The global Metastatic Uveal Melanoma Thereapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Metastatic Uveal Melanoma Thereapeu…